United Therapeutics UTHR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.28B-17.8% | $1.56B+16.2% | $1.34B-15.9% | $1.59B-16.1% | $1.9B+11.9% | ||
| $874M-35.9% | $1.36B-4.5% | $1.43B-1.9% | $1.46B+2.4% | $1.42B-9.5% | ||
| $312M-10.9% | $350.2M+17.6% | $297.7M-21.5% | $379.3M+17.8% | $322M+15.3% | ||
| $178.3M-2.6% | $183.1M+3.7% | $176.5M+4.3% | $169.2M+2.3% | $165.4M+4.7% | ||
| $228M-8.4% | $248.9M-1.3% | $252.2M+9.8% | $229.7M+75.2% | $131.1M-22.7% | ||
| $2.87B-22.4% | $3.7B+6.0% | $3.49B-8.7% | $3.83B-2.9% | $3.94B+1.7% | ||
| $1.84B+6.4% | $1.73B+11.2% | $1.56B+14.2% | $1.36B+4.6% | $1.3B+6.6% | ||
| $115.5M-0.9% | $116.5M-0.2% | $116.7M+4.7% | $111.5M-0.2% | $111.7M-0.2% | ||
| $335.4M-6.2% | $357.7M+0.8% | $354.9M-22.2% | $456.2M-0.1% | $456.6M-0.4% | ||
| $233.2M+18.4% | $196.9M-25.0% | $262.6M+12.6% | $233.3M+4.9% | $222.4M+0.1% | ||
| $6.71B-14.8% | $7.88B+7.2% | $7.35B-7.0% | $7.91B+2.1% | $7.74B+5.2% | ||
| $498.3M+2.1% | $488M+4.3% | $468M+8.3% | $432M+17.7% | $367M+6.5% | ||
| $100.8M+38.8% | $72.6M-7.3% | $78.3M-17.7% | $95.1M-38.4% | $154.5M+65.1% | ||
| $599.1M+6.9% | $560.6M+2.6% | $546.3M+3.6% | $527.1M-26.9% | $721.5M-2.2% | ||
| $214M-4.1% | $223.2M+4.0% | $214.6M+3.5% | $207.3M-3.7% | $215.2M+18.3% | ||
| $813.1M+3.7% | $783.8M+3.0% | $760.9M+3.6% | $734.4M-21.6% | $936.7M+1.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $800K0.0% | $800K0.0% | $800K0.0% | $800K0.0% | $800K0.0% | ||
| $2.52B-9.9% | $2.8B+5.2% | $2.66B-4.8% | $2.79B+2.0% | $2.74B+1.4% | ||
| $8.83B+3.2% | $8.56B+4.4% | $8.19B+4.3% | $7.85B+4.1% | $7.54B+4.5% | ||
| -$10.2M-1,233% | $900K+800% | $100K— | $0+100% | -$1.2M+64.7% | ||
| $5.44B+27.7% | $4.26B0.0% | $4.26B+22.7% | $3.47B0.0% | $3.47B0.0% | ||
| $5.9B-16.8% | $7.1B+7.7% | $6.59B-8.1% | $7.17B+5.4% | $6.81B+5.6% | ||
| $6.71B-14.8% | $7.88B+7.2% | $7.35B-7.0% | $7.91B+2.1% | $7.74B+5.2% | ||
| $874M-35.9% | $1.36B-4.5% | $1.43B-1.9% | $1.46B+2.4% | $1.42B-9.5% | ||
| $228M-8.4% | $248.9M-1.3% | $252.2M+9.8% | $229.7M+75.2% | $131.1M-22.7% | ||
| $233.2M+18.4% | $196.9M-25.0% | $262.6M+12.6% | $233.3M+4.9% | $222.4M+0.1% | ||
| $115.5M-0.9% | $116.5M-0.2% | $116.7M+4.7% | $111.5M-0.2% | $111.7M-0.2% | ||
| $335.4M-6.2% | $357.7M+0.8% | $354.9M-22.2% | $456.2M-0.1% | $456.6M-0.4% | ||
| $115.5M-0.9% | $116.5M-0.2% | $116.7M+4.7% | $111.5M-0.2% | $111.7M-0.2% | ||
| $233.2M+18.4% | $196.9M-25.0% | $262.6M+12.6% | $233.3M+4.9% | $222.4M+0.1% | ||
| $233.2M+18.4% | $196.9M-25.0% | $262.6M+12.6% | $233.3M+4.9% | $222.4M+0.1% | ||
| $498.3M+2.1% | $488M+4.3% | $468M+8.3% | $432M+17.7% | $367M+6.5% | ||
| $100.8M+38.8% | $72.6M-7.3% | $78.3M-17.7% | $95.1M-38.4% | $154.5M+65.1% | ||
| $2.52B-9.9% | $2.8B+5.2% | $2.66B-4.8% | $2.79B+2.0% | $2.74B+1.4% | ||
| $800K0.0% | $800K0.0% | $800K0.0% | $800K0.0% | $800K0.0% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are United Therapeutics's total assets?
- United Therapeutics (UTHR) holds $6.7B in total assets, down 13.3% year over year.
- How much cash does United Therapeutics have?
- United Therapeutics holds $1.3B in cash and equivalents.
- Can United Therapeutics cover its short-term obligations?
- Its current ratio is 4.79 — current assets exceed current liabilities.
- Where does United Therapeutics's balance sheet data come from?
- Every line is extracted from United Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
